Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism

scientific article published on 09 October 2009

Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/JC.2009-0179
P8608Fatcat IDrelease_bjtmss6pgzhttp2cq2wamhycze
P932PMC publication ID2775659
P698PubMed publication ID19820032
P5875ResearchGate publication ID26885791

P50authorTaneli RaivioQ30347924
Moosa MohammadiQ37382162
Andrew A DwyerQ50423876
Nelly PitteloudQ88221528
Richard QuintonQ90569845
Elka Jacobson-DickmanQ106489349
Lacey PlummerQ106489974
Guy Van VlietQ112075351
Yisrael SidisQ114419631
Huaibin ChenQ114419645
Helene LavoieQ114419646
P2093author name stringFrances J Hayes
Jinghong Ma
Ursula B Kaiser
Susan Sparks
Abir Mukherjee
Shuyun Xu
Virginia A Hughes
P2860cites workKallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2Q21092497
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerizationQ24290400
Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and miceQ24309428
A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding moleculesQ24311797
Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndromeQ24657612
Hypogonadotropic hypogonadism and cleft lip and palate caused by a balanced translocation producing haploinsufficiency for FGFR1Q24673321
Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadismQ24675675
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54Q24685744
A Molecular Brake in the Kinase Hinge Region Regulates the Activity of Receptor Tyrosine KinasesQ27647832
Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanismQ27733279
The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion moleculesQ28118633
The GPR54 gene as a regulator of pubertyQ28211950
Novel FGFR1 sequence variants in Kallmann syndrome, and genetic evidence that the FGFR1c isoform is required in olfactory bulb and palate morphogenesisQ28277862
NMR structure of the first Ig module of mouse FGFR1Q30159788
Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismQ30442563
Identical twins discordant for Kallmann's syndromeQ33597467
Protein glucosylation and its role in protein foldingQ34019347
Quality control of mRNA functionQ34156109
Sex differences in odor identification ability: a cross-cultural analysisQ34200570
A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptorQ34446712
Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypesQ34568239
Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadismQ34597433
TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproductionQ34902985
Structural basis for fibroblast growth factor receptor activationQ36111391
A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadismQ36697937
Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.Q36938312
Fibroblast growth factor 8 signaling through fibroblast growth factor receptor 1 is required for the emergence of gonadotropin-releasing hormone neurons.Q36972716
Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.Q37012242
Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization.Q38297297
Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesisQ38326603
Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormoneQ39588133
Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis.Q40508811
The rat osteocalcin fibroblast growth factor (FGF)-responsive element: an okadaic acid-sensitive, FGF-selective transcriptional response motifQ41178871
Role of the extracellular regions of the parathyroid hormone (PTH)/PTH-related peptide receptor in hormone bindingQ41441064
The fertile eunuch variant of idiopathic hypogonadotropic hypogonadism: spontaneous reversal associated with a homozygous mutation in the gonadotropin-releasing hormone receptorQ43633820
Spontaneous pregnancy in a patient who was homozygous for the Q106R mutation in the gonadotropin-releasing hormone receptor geneQ44022898
GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormoneQ44968726
Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.Q47998798
FGF signaling through FGFR1 is required for olfactory bulb morphogenesisQ48394629
Recommendations for a nomenclature system for human gene mutations. Nomenclature Working GroupQ48771295
Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndromeQ50336618
Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome.Q52561443
Reversal of idiopathic hypogonadotropic hypogonadismQ55847307
Induction of urokinase-type plasminogen activator by fibroblast growth factor (FGF)-2 is dependent on expression of FGF receptors and does not require activation of phospholipase Cgamma1Q57947452
Novel Fibroblast Growth Factor Receptor 1 Mutations in Patients with Congenital Hypogonadotropic Hypogonadism with and without AnosmiaQ60677985
Cell type and tissue distribution of the fibroblast growth factor receptorQ69349224
Characterization of pp60c-src Tyrosine Kinase Activities Using a Continuous Assay: Autoactivation of the Enzyme Is an Intermolecular Autophosphorylation ProcessQ71786430
Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadismQ73739026
Free alpha-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequenciesQ74619301
The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadismQ77481466
Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerationsQ77481731
Heterogeneity of Kallmann's syndromeQ93612663
P433issue11
P407language of work or nameEnglishQ1860
P921main subjecthypogonadismQ938107
hypogonadotropic hypogonadismQ30990102
P304page(s)4380-4390
P577publication date2009-10-09
P1433published inThe Journal of Clinical Endocrinology and MetabolismQ3186902
P1476titleImpaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism
P478volume94

Reverse relations

cites work (P2860)
Q24613193A genetic basis for functional hypothalamic amenorrhea
Q35442176A shared genetic basis for self-limited delayed puberty and idiopathic hypogonadotropic hypogonadism
Q40706883Bone involvement in males with Kallmann disease
Q30848681Combined pituitary hormone deficiency: current and future status
Q35602910Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutations.
Q87993928Discovering Genes Essential to the Hypothalamic Regulation of Human Reproduction Using a Human Disease Model: Adjusting to Life in the "-Omics" Era
Q36433718Discovering Genes Essential to the Hypothalamic Regulation of Human Reproduction Using a Human Disease Model: Adjusting to Life in the "-Omics" Era.
Q30426059Disease-causing mutation in extracellular and intracellular domain of FGFR1 protein: computational approach
Q37336121Dominant-negative kinase domain mutations in FGFR1 can explain the clinical severity of Hartsfield syndrome
Q28386577Expanding the phenotype and genotype of female GnRH deficiency
Q35458207FGFR1 and PROKR2 rare variants found in patients with combined pituitary hormone deficiencies
Q34632015Fibroblast growth factor signaling in the developing neuroendocrine hypothalamus
Q36100642Genetic Overlap between Holoprosencephaly and Kallmann Syndrome.
Q89687374Genetic causes of hypopituitarism
Q30439081Genetic rescue of Muenke syndrome model hearing loss reveals prolonged FGF-dependent plasticity in cochlear supporting cell fates
Q48240276Genetic testing facilitates prepubertal diagnosis of congenital hypogonadotropic hypogonadism.
Q24307650Heparan sulfate 6-O-sulfotransferase 1, a gene involved in extracellular sugar modifications, is mutated in patients with idiopathic hypogonadotrophic hypogonadism
Q35126506Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland
Q41889886KLB, encoding β-Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism
Q24337453Leucine-rich repeat, immunoglobulin-like and transmembrane domain 3 (LRIT3) is a modulator of FGFR1
Q26770529MANAGEMENT OF ENDOCRINE DISEASE: Reversible hypogonadotropic hypogonadism
Q37060756Molecular basis for the Kallmann syndrome-linked fibroblast growth factor receptor mutation.
Q34342881Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism
Q34093958Oligogenic basis of isolated gonadotropin-releasing hormone deficiency.
Q36760693PROK2/PROKR2 Signaling and Kallmann Syndrome.
Q38822960Perspectives in Pediatric Pathology, Chapter 18. Hypogonadotropic Hypogonadisms. Pediatric and Pubertal Presentations
Q36589407Responsiveness to a physiological regimen of GnRH therapy and relation to genotype in women with isolated hypogonadotropic hypogonadism
Q34397759Reversal and relapse of hypogonadotropic hypogonadism: resilience and fragility of the reproductive neuroendocrine system.
Q21134513Reversible congenital hypogonadotropic hypogonadism in patients with CHD7, FGFR1 or GNRHR mutations
Q35256026Role of fibroblast growth factor (FGF) signaling in the neuroendocrine control of human reproduction
Q40167352Spectrum of phenotype and genotype of congenital isolated hypogonadotropic hypogonadism in Asian Indians
Q36613472The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome
Q49437047Update on the Genetics of Idiopathic Hypogonadotropic Hypogonadism
Q36283451Variants in congenital hypogonadotrophic hypogonadism genes identified in an Indonesian cohort of 46,XY under-virilised boys.
Q37187461Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease

Search more.